This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

They are doing us proud at the moment given they are fighting against the markets and Evil.
DB66

We are doing ourselves proud fighting Evil. Got in again today at 192p.

Please just stand firm.

cheers GF.

I do stand firm, gf. bought in @295, even no more cash to top, no quitting!! swseun

Under pressure at the moment.

cheers GF.

Hi everyone including Ginger and gf...been busy moving house this past week and so had no time to post but should be back to normal by next week..meantime MMG's sp looks very strong at 190p so just wait till next Tuesday to breach the 200p level..cheers.
gf; good find re the Cambridge news.

Will be glad to see you back on here monday Mitzy. Youve certainly been missed.

cheers GF.

A positive end to the day?, lets hope so.

cheers GF.

From the other place. A must watch for those who hold.

mandafund - 21 Apr'05 - 15:41 - 5146 of 5148


For those who have not received an invite for the R&D presentation you can follow proceedings via a live web cast which includes slides at the following address:

http://mediaserve.buchanan.uk.com

The link for MMI should appear next Tuesday

Hope this works for everyone and dont forget to top up before Tuesday as it could go orbital!

MS

Welcome back Mitzy , Great post from Cambridge News Goldfinger it certainly fills you with confidence.Also i must not forget Mickey another good post,i will certainly give that link a go.
Dow is well up as i sit here so if it stays that way i think we are certainly on the move up and with only a couple of trading days left before presentation now is the time to buy.
Onward and upwards
DB66

Agreed DB.

cheers gf.

Im hoping to get back in soon,,don't want to be left out,, don't know what to sell ..JB..

I have a sizeable holding in MMG now & have been buying several tranches. However one questions I have is why hasn't the Share magazine (which I buy every week) covered this share. It wasn't even mentioned when the SP was around the 3 mark. Any ideas ?

More Good News from MMG

"Medical Marketing Int'l Group PLC
22 April 2005


FOR IMMEDIATE RELEASE 22nd APRIL 2005


MMI TO BE GRANTED
FURTHER US AND EUROPEAN PATENTS FOR ANTI CANCER THERAPY

Significantly strengthens patent position for Ruthenium

Medical Marketing International Group plc ('MMI') (AIM: MMG), the Cambridge,
UK-based pharmaceutical company focussed on the development of therapies for
cancer and infectious diseases, announces that it has been formally notified of
allowance of claims for two further patents by the US Patent Office and the
European Patent Office for its ruthenium-based anti-cancer therapy, being
developed by MMI's wholly-owned cancer therapy subsidiary Oncosense. These two
patents will be granted, following payment of standard fees.

These two further patents significantly strengthen MMI's protection for its
whole ruthenium library of compounds and importantly give further protection to
the Company's lead compounds that will enter into clinical development in 2005.

Commenting on today's news, David Best, Chairman of MMI Group said: 'Receiving
notifications of grant of two significant patents in the two biggest markets is
extremely good news for MMI. The new USA and EU patents, when combined with
those granted in these territories last year enhance our library of ruthenium
cancer therapies and also provide solid patent protection for our lead ruthenium
compounds.


"Commercially, it is also extremely important news. Potential marketing partners
are primarily interested in a strong patent portfolio and good clinical data.
Today's news will strengthen our negotiating position.'

As announced earlier this week, MMI will be hosting its first R&D Day on Tuesday
26th April 2005. Further details on its ruthenium portfolio together with
Genvax, its DNA cancer vaccine platform and other key developments will be given
at this time.


For further information, please contact:

David Best - Executive Chairman
MMI Group "

Baza

great news.

Great - now lets shake out these shorters and hope EK & freinds get their fingers burnt. All those who kept the faith will get their rewards.

Pumben:

No mention in Shares mag yesterday and nothing in todays IC...not unusual by any means.

Mitzy,, i agree you would think with the ups and downs of MMG over the last months there would have been mention,, any reason why not ??..JB..

Mitzy

Thanks. Excellent news this morning. The newsflow this week has been great, hopefully all coming to boil & lets hope EK is boiled at the same time.

Companies like this need all the support they can get when it is working on products which are for the good of the human race !!!